Tweenvest Stocks

Grey Matters Health Inc. (CNSX: GREY)

Health Care · Pharmaceuticals · CA

CA$0.39

+1.32% today · -48.7% 1Y

Grey Matters Health Inc. (CNSX: GREY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.05M and employs 5 people.

Over the last twelve months the share price has lost 48.7%, trading between 0.34 and 0.90.

Tweenvest scores Grey Matters Health Inc. across four factors: quality 26/100, value 77/100. Its strongest factor is value.

GREY price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$3.05M
Revenue (TTM)
—
P/E
—
EPS
-0.51
Dividend yield
—
Beta (5Y)
1.09
52-week high
CA$0.90
52-week low
CA$0.34
Avg volume (3M)
—
Shares outstanding
11.30M
Employees
5
Next earnings
—

About Grey Matters Health Inc.

Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

ISIN
CA3978841078
Founded
2015
Listed since
Feb 1, 2016
Exchange
Canadian National Stock Exchange
Currency
CAD
CompanyMarket capPriceDay
Cadrenal Therapeutics, Inc.NasdaqCM: CVKD$3.25M$0.82-10.19%
Goldline Pharmaceutical LimitedBSE: 544759$3.22MRs32.50+4.94%
Herbal Dispatch Inc.CNSX: HERB$3.21MCA$0.04+16.67%
PRF Technologies Ltd.NasdaqCM: PRFX$3.08M$0.86-2.33%
Emmaus Life Sciences, Inc.OTCPK: EMMA$3.00M$0.04+1.42%
Nextleaf Solutions Ltd.CNSX: OILS$2.98MCA$0.03-16.67%
Medicamen Organics LimitedNSEI: MEDIORG$2.94MRs23.35-4.89%
Nextgen Biomed LtdTASE: NXGN-M$2.93M₪——

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.